Reports for MYLAN PHARMACEUTICALS ULC

Company Name

MYLAN PHARMACEUTICALS ULC

Totals

Shortage reports

654

Actual shortage: 16 (2%)
Anticipated shortage: 6 (1%)
Avoided shortage: 85 (13%)
Resolved: 547 (84%)

Discontinuation Reports

234

To be discontinued: 0 (0%)
Discontinued: 234 (100%)
Reversed: 0 (0%)

Late reports

83 (9%)

Overdue reports

2 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-MIRTAZAPINE 15MG TABLET Resolved 2019-05-28 2019-07-17 85061
MYLAN-MIRTAZAPINE 45MG TABLET Resolved 2020-01-28 2020-02-20 104515
MYLAN-MIRTAZAPINE 15MG TABLET Resolved 2020-09-01 2020-09-10 123514
MYLAN-MIRTAZAPINE 30MG TABLET Avoided shortage 2021-10-13 2021-10-26 146990
MYLAN-MIRTAZAPINE 15MG TABLET Resolved 2022-08-03 2023-10-03 166037
MYLAN-MIRTAZAPINE 30MG TABLET Resolved 2023-01-23 2023-07-14 182205
MYLAN-MIRTAZAPINE 45MG TABLET Resolved 2023-03-07 2023-10-03 186407
MYLAN-MIRTAZAPINE 30MG TABLET Avoided shortage 2023-08-01 2023-10-03 200648
MYLAN-MIRTAZAPINE 30MG TABLET Resolved 2024-01-22 2024-05-09 216953
MYLAN-MIRTAZAPINE 45MG TABLET Actual shortage 2024-06-11 2024-06-13 230092
MYLAN-MONTELUKAST 10MG TABLET Avoided shortage 2017-04-07 2017-05-05 5946
MYLAN-MONTELUKAST 4MG TABLET (CHEWABLE) Resolved 2017-04-13 2017-09-08 7052
MYLAN-MONTELUKAST 10MG TABLET Resolved 2017-04-13 2017-12-08 7055
MYLAN-MONTELUKAST 5MG TABLET (CHEWABLE) Resolved 2017-05-05 2018-02-15 9241
MYLAN-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2017-04-07 2018-07-11 5916
MYLAN-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2017-12-21 2018-07-11 34097
MYLAN-NAPROXEN/ESOMEPRAZOLE MR 20MG 500MG TABLET (IMMEDIATE AND DELAYED-RELEASE) Avoided shortage 2019-06-04 2019-06-18 85554
MYLAN-NAPROXEN/ESOMEPRAZOLE MR 20MG 500MG TABLET (IMMEDIATE AND DELAYED-RELEASE) Resolved 2017-06-21 2019-05-23 13528
MYLAN-NAPROXEN/ESOMEPRAZOLE MR 20MG 375MG TABLET (IMMEDIATE AND DELAYED-RELEASE) Resolved 2017-06-21 2018-02-03 13532
MYLAN-NAPROXEN/ESOMEPRAZOLE MR 20MG 500MG TABLET (IMMEDIATE AND DELAYED-RELEASE) Resolved 2019-06-25 2019-07-17 87460

Showing 401 to 420 of 654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-08-24 2018-02-15 20259
MYLAN-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-08-24 2018-02-15 20287
MYLAN-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-08-24 2018-07-04 20306
MYLAN-VERAPAMIL 80MG TABLET Discontinued 2024-04-11 2024-04-12 224846
MYLAN-ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-06-06 2018-07-04 51653
MYLAN-ZOPICLONE 5MG TABLET Discontinued 2018-05-04 2018-05-04 48576
MYLAN-ZOPICLONE 7.5MG TABLET Discontinued 2018-06-06 2018-07-04 51665
ONDANSETRON INJECTION, USP 2MG SOLUTION SOLUTION Discontinued 2022-05-11 2022-05-11 160318
ONDANSETRON INJECTION, USP 2MG SOLUTION Discontinued 2022-05-11 2022-05-11 160323
TOBRAMYCIN INJECTION, USP 40MG SOLUTION Discontinued 2022-01-12 2022-01-12 152485
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP 500MG POWDER FOR SOLUTION Discontinued 2018-06-06 2018-06-08 51668
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP 1G POWDER FOR SOLUTION Discontinued 2018-06-06 2018-06-08 51671
VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP 5G POWDER FOR SOLUTION Discontinued 2018-06-06 2018-06-08 51674
MYLAN-ZOLMITRIPTAN 2.5MG TABLET Discontinued 2018-06-06 2018-07-04 51647

Showing 221 to 234 of 234